UCB · 23 hours ago
Global Head, Data Evaluation and Enablement
UCB is a global biopharmaceutical company, focusing on neurology and immunology. They are seeking a Global Head of Data Evaluation and Enablement to define and lead the enterprise strategy for operationalizing patient level data, ensuring high quality and compliance while driving data strategy and governance.
BiotechnologyHealth CarePharmaceutical
Responsibilities
Lead and develop a high‑performing team focused on data evaluation, ownership, and enablement
Set direction and oversee performance of enterprise data programs to ensure quality and compliance
Drive strategic planning for enablement frameworks including tokenization and data quality management
Promote adoption and effective use of patient‑level data through training and communication
Lead change management and continuous improvement to maximize data value
Build deep expertise in real‑world data, including claims, labs, and unstructured data
Ensure clear communication, transparency, and stakeholder alignment across functions
Partner with IT, Data Office, and external vendors to ensure data and platform accessibility
Oversee onboarding and operationalization of contracted data sources
Develop data literacy training and communication for enterprise users
Qualification
Required
Bachelor's degree in quantitative area
Minimum of 10 years' experience working with various forms of patient level pharmaceutical data
Minimum of 5 years of experience leading data operations
Preferred
Master/Doctor's degree in quantitative area is preferred
Company
UCB
At UCB, we believe everyone deserves to live the best life they can - as free as possible from the challenges and uncertainty of disease.
H1B Sponsorship
UCB has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (5)
2024 (7)
2023 (3)
2022 (4)
2021 (4)
2020 (1)
Funding
Current Stage
Public CompanyTotal Funding
$201.75MKey Investors
Financière de Tubize SAPaul Capital
2022-05-23Post Ipo Equity· $100.96M
2015-05-13Post Ipo Equity· $0.79M
2009-12-22Post Ipo Equity· $100M
Leadership Team
Recent News
Company data provided by crunchbase